adenosine monophosphate has been researched along with Dyspnea in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 6 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Cheong, HJ; Choi, YJ; Hyun, H; Kim, WJ; Nham, E; Noh, JY; Seong, H; Song, JY; Yoon, JG | 1 |
| Aldrich, M; Cabana, MD; Chao, JY; Derespina, KR; Goldman, DL; Herold, BC; Medar, SS; Ushay, HM; Weingarten, J | 1 |
| Berlin, DA; Gulick, RM; Martinez, FJ | 1 |
| Brown, JC; Cordova, FC; Criner, GJ; Galli, JA; Mamary, AJ; Marchetti, N; Mulhall, PD; Myers, CN; Scott, JH; Sehgal, S; Shenoy, KV; Shigemura, N | 1 |
| Bebell, LM; Brigl, M; Matias, WR; Vaidya, A | 1 |
| Agostini, C; Bernardo, P; Caniato, F; Cappelli, F; Di Filippo, C; Di Mario, C; Mattesini, A; Meucci, F; Sori, A; Stolcova, M | 1 |
| Bhatt, DL; Day, JRS; Gibson, CM; Hamm, CW; Mahaffey, KW; Parker, WA; Prats, J; Price, MJ; Steg, PG; Stone, GW; Storey, RF; White, HD | 1 |
| Barnes, PJ; Basoglu, OK; Kharitonov, SA; Pelleg, A | 2 |
| Boudewijn, IM; Cox, CA; Farenhorst, MP; Frijlink, HW; Hagedoorn, P; Kerstjens, HAM; Lexmond, AJ; Schokker, S; Ten Hacken, NHT; van den Berge, M; Vonk, JM; Vroegop, SJ | 1 |
| DiNicolantonio, JJ; Serebruany, VL; Sibbing, D | 1 |
| Jover, E; Tello-Montoliu, A; Valdés, M | 1 |
| Caldeira, D; Ferreira, JJ; Pinto, FJ | 1 |
| De Jongste, JC; Hoogsteden, HC; Overbeek, SE; Prins, JB; van den Toorn, LM | 1 |
| Barnes, PJ; Basoglu, OK; Brindicci, C; Essilfie-Quaye, S; Kharitonov, SA; Pelleg, A | 1 |
| Koeter, GH; Postma, DS; Rutgers, SR; ten Hacken, NH | 1 |
4 review(s) available for adenosine monophosphate and Dyspnea
| Article | Year |
|---|---|
Severe Covid-19.
Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Brain; COVID-19; COVID-19 Testing; Dexamethasone; Dyspnea; Humans; Lung; Male; Middle Aged; Patient Acuity; Radiography, Thoracic; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |
Dyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyond.
Topics: Acute Lung Injury; Adenosine; Adenosine Monophosphate; Administration, Oral; Clopidogrel; Dyspnea; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Quinazolinones; Randomized Controlled Trials as Topic; Sulfonamides; Ticagrelor; Ticlopidine; Transfusion Reaction | 2014 |
[New antiplatelet drugs in coronary artery disease].
Topics: Adenosine; Adenosine Monophosphate; Clinical Trials, Phase III as Topic; Coronary Artery Disease; Double-Blind Method; Dyspnea; Hemorrhage; Humans; Multicenter Studies as Topic; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Receptors, Proteinase-Activated; Thiophenes; Ticagrelor; Treatment Outcome | 2014 |
Dyspnea and reversibility profile of P2Y₁₂ antagonists: systematic review of new antiplatelet drugs.
Topics: Adenosine; Adenosine Monophosphate; Clopidogrel; Dyspnea; Humans; Incidence; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Quinazolinones; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Sulfonamides; Thiophenes; Ticagrelor; Ticlopidine | 2014 |
3 trial(s) available for adenosine monophosphate and Dyspnea
| Article | Year |
|---|---|
Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study.
Topics: Adenosine Monophosphate; Aged; Clopidogrel; Coronary Occlusion; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Dyspnea; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Percutaneous Coronary Intervention; Receptors, Purinergic P2Y12; Survival Analysis; Ticlopidine; Treatment Outcome; Withholding Treatment | 2017 |
Contrasting effects of ATP and adenosine on capsaicin challenge in asthmatic patients.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Adult; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstriction; Capsaicin; Case-Control Studies; Cough; Double-Blind Method; Dyspnea; Female; Forced Expiratory Volume; Humans; Male; Prospective Studies; Smoking | 2017 |
Effects of aerosolized adenosine 5'-triphosphate vs adenosine 5'-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Adult; Aerosols; Asthma; Double-Blind Method; Dyspnea; Female; Forced Expiratory Volume; Humans; Male; Reference Values; Skin Tests; Smoking | 2005 |
9 other study(ies) available for adenosine monophosphate and Dyspnea
| Article | Year |
|---|---|
Prognostic factors of 30-day mortality in patients with COVID-19 pneumonia under standard remdesivir and dexamethasone treatment.
Topics: Adenosine Monophosphate; Aged; Alanine; Anti-Bacterial Agents; C-Reactive Protein; COVID-19 Drug Treatment; Dexamethasone; Dyspnea; Humans; Lactate Dehydrogenases; Pneumonia; Prognosis; Retrospective Studies; SARS-CoV-2 | 2022 |
Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City.
Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; Asthma; Betacoronavirus; Blood Urea Nitrogen; C-Reactive Protein; Child; Child, Preschool; Coronavirus Infections; COVID-19; Creatinine; Critical Illness; Dyspnea; Female; Hospitalization; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Natriuretic Peptide, Brain; New York City; Pandemics; Pediatric Obesity; Platelet Count; Pneumonia, Viral; Procalcitonin; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Sepsis; Shock, Septic; Tertiary Care Centers; Young Adult | 2020 |
COVID-19 in lung transplant recipients.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Cough; COVID-19; Cross Infection; Cystic Fibrosis; Dyspnea; Female; Fever; Gastrointestinal Diseases; Glucocorticoids; Graft Rejection; Humans; Idiopathic Pulmonary Fibrosis; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Lung; Lung Transplantation; Male; Methylprednisolone; Middle Aged; Pancreatitis, Acute Necrotizing; Pulmonary Disease, Chronic Obstructive; Pulse Therapy, Drug; SARS-CoV-2; Sepsis; Severity of Illness Index; Tomography, X-Ray Computed | 2020 |
A Patient with Fever and Dyspnea.
Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Combined Modality Therapy; COVID-19; Dexamethasone; Diagnosis, Differential; Dyspnea; Female; Fever; Humans; Leukocyte Count; Lung; Middle Aged; Myalgia; Nasopharynx; Oxygen; Radiography, Thoracic; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2 | 2020 |
Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty.
Topics: Adenosine Monophosphate; Aged; Anxiety; Chest Pain; Coronary Angiography; Coronary Occlusion; Drug Substitution; Drug-Eluting Stents; Drug-Related Side Effects and Adverse Reactions; Dyspnea; Electrocardiography; Humans; Inferior Wall Myocardial Infarction; Male; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Treatment Outcome; Withholding Treatment | 2021 |
Associations of AMP and adenosine induced dyspnea sensation to large and small airways dysfunction in asthma.
Topics: Adenosine; Adenosine Monophosphate; Adult; Asthma; Bronchi; Bronchial Provocation Tests; Bronchoconstrictor Agents; Dyspnea; Female; Forced Expiratory Volume; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Spirometry | 2019 |
Effects of Aerosolized Adenosine 5'-Triphosphate in Smokers and Patients With COPD.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Administration, Inhalation; Adult; Breath Tests; Bronchi; Bronchoconstriction; Case-Control Studies; Cough; Dyspnea; Female; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Smoking | 2015 |
Dyspnoea perception during clinical remission of atopic asthma.
Topics: Adenosine Monophosphate; Adult; Asthma; Bronchial Hyperreactivity; Bronchoconstrictor Agents; Cross-Sectional Studies; Dyspnea; Female; Forced Expiratory Volume; Humans; Male; Methacholine Chloride; Perception; Remission, Spontaneous | 2002 |
Borg scores before and after challenge with adenosine 5'-monophosphate and methacholine in subjects with COPD and asthma.
Topics: Adenosine Monophosphate; Adolescent; Adult; Aged; Asthma; Bronchial Provocation Tests; Dyspnea; Female; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; Male; Methacholine Chloride; Middle Aged; Smoking | 2000 |